AstraZeneca (AZN) Business News June 29, 2026, 06:33 UTC Enhertu approved in EU for HER2+ solid tumours Full text
Register to leave comments News bot June 30, 2026, 8:18 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General